Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Galmed Pharmaceuticals Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

21 Feb 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - GALMED PHARMACEUTICALS LTD (GLMD-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 Feb 2015 Thomson Reuters Stock Report 10 $25.00

ValuEngine Industry Report for Medical-drugs(GLMD)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

26 Feb 2015 ValuEngine, Inc. 10 $49.00

GALMED PHARMACEUTICALS LTD (GLMD) - REPORT FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

21 Feb 2015 Pechala's Reports 1 $25.00

GALMED PHARMACEUTICALS LTD (GLMD) 12-months forecast

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

21 Feb 2015 Pechala's Reports 1 $15.00

GALMED PHARMACEUTICALS- ARAMCHOL CLEARED TO START KEY NASH TRIAL

Galmed’s aramchol is expected to start a Phase IIb study in late 2014 for non-alcoholic steatohepatitis (NASH), an area that ...

18 Aug 2014 Edison Investment Research 2 $10.00